Nicholas Lydon

Director, Blueprint Medicines Corp.

Companies

Blueprint Medicines CorpBoard member Apr 30, 2015 to now¹
ANAPTYSBIO, INCBoard member Jan 25, 2017 to Feb 11, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Blueprint Medicines Corp58,026 shares³Jun 12, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 12, 2024Granted 2,242 shares of Blueprint Medicines Corp³
Jun 21, 2023Granted 2,600 shares of Blueprint Medicines Corp⁴
Jun 21, 2022Granted 2,600 shares of Blueprint Medicines Corp⁵
May 23, 2022Exercised options 10,909 shares at $19.53 of Blueprint Medicines Corp⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBlueprint Medicines Corp, Board member
2
SEC EDGARANAPTYSBIO, INC, Board member
3
SEC EDGARBlueprint Medicines Corp shares after the filing of Jun 12, 2024
4
SEC EDGARForm 4 filed Jun 23, 2023
5
SEC EDGARForm 4 filed Jun 30, 2022
6
SEC EDGARForm 4 filed May 25, 2022